| Adam H. Schechter |
President & CEO, Director |
$28,682,362 |
-$6,030,754 |
-17% |
11 Nov 2025 |
| GLENN A. EISENBERG |
Executive Vice President |
$10,666,073 |
|
|
27 Mar 2025 |
| Brian J. Caveney |
EVP, Pres of ED, CMO & CSO |
$8,453,110 |
-$494,000 |
-5.5% |
03 Jun 2025 |
| LANCE BERBERIAN |
EVP, Special Advisor, Strategy |
$4,582,673 |
|
|
27 Mar 2025 |
| JEAN-LUC BELINGARD |
Director |
$4,029,843 |
|
|
06 Feb 2024 |
| Thomas Pike |
Pres & CEO Clinical Business |
$3,573,692 |
|
|
09 Jan 2023 |
| Paul R. Kirchgraber |
CEO, Covance Drug Development |
$3,473,997 |
|
|
19 May 2023 |
| PETER M. NEUPERT |
Director |
$3,249,349 |
|
|
11 Feb 2025 |
| Garheng Kong |
Director |
$3,238,774 |
|
|
11 Feb 2025 |
| KERRII B. ANDERSON |
Director |
$2,647,384 |
-$2,585,317 |
-49% |
24 Jul 2025 |
| Mark S. Schroeder |
EVP, Pres Diagnostics & COO |
$2,273,818 |
-$1,941,089 |
-46% |
27 Mar 2025 |
| Dwight Gary Gilliland |
Director |
$1,984,411 |
-$529,900 |
-21% |
30 Jul 2025 |
| R. Sanders Williams |
Director |
$1,869,321 |
|
|
06 Feb 2024 |
| Megan D. Bailey |
EVP, Pres, Central Labs & Intl |
$1,614,504 |
|
|
01 Nov 2025 |
| Jonathan P. DiVincenzo |
EVP, Pres, Central Labs & Intl |
$1,609,566 |
|
|
27 Mar 2024 |
| Amy B. Summy |
EVP, Chief Marketing Officer |
$1,561,344 |
-$232,196 |
-13% |
27 Mar 2025 |
| Akinbolade Oyegunwa |
Evp, Cio & Cto |
$1,529,671 |
|
|
01 Nov 2025 |
| Jeffrey A. Davis |
Director |
$1,293,209 |
|
|
11 Feb 2025 |
| Judith C. Seltz |
Evp, Chro |
$1,226,422 |
|
|
30 Mar 2023 |
| Julia Aijun Wang |
Chief Financial Officer, EVP |
$1,213,452 |
|
|
11 Feb 2025 |
| Sandra D. van der Vaart |
EVP, Chief Legal Officer |
$1,170,411 |
-$1,842,464 |
-61% |
13 Aug 2025 |
| Peter J. Wilkinson |
SVP, Chief Accounting Officer |
$1,094,138 |
-$601,303 |
-35% |
29 Jul 2025 |
| Kathryn E. Wengel |
Director |
$981,364 |
|
|
11 Feb 2025 |
| Richelle P. Parham |
Director |
$848,729 |
-$1,782,273 |
-68% |
31 Oct 2025 |
| Paul Rothman |
Director |
$813,322 |
|
|
11 Feb 2025 |
| Kirsten Kliphouse |
Director |
$752,709 |
|
|
11 Feb 2025 |
| ANITA Z. GRAHAM |
Evp, Chro |
$697,291 |
|
|
11 Feb 2025 |
| Victor Bulto |
Director |
|
|
|
01 Dec 2025 |